FDA approves Axogen's nerve repair graft
Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's AXGN.O nerve repair graft, the health regulator said on Wednesday. (Reporting by Sriparna Roy, Padmanabhan Ananthan and Puyaan Singh in Bengaluru; Editing by Sherry Jacob-Phillips) ((Sriparna.Roy@thomsonreuters.com;))